Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Person › Details

J. Donald deBethizy (Santaris Pharma A/S)

deBethizy, J. Donald (Santaris Pharma 201401– CEO before Targacept CEO)

	Organisation	Santaris Pharma A/S
	Today	Roche Innovation Center Copenhagen
	Group	Roche (Group)
	Former/major organisation	Targacept Inc. (Nasdaq: TRGT)
	Today	Catalyst Biosciences Inc. (Nasdaq: CBIO)
	Group	Catalyst Biosciences Inc. (Nasdaq: CBIO)
	Product	LNA™ technology (Locked Nucleic Acid)

Record changed: 2020-06-26

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for J. Donald deBethizy

[1] Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer"....
[2] Noxxon Pharma N.V.. (9/29/17). "Press Release: Noxxon Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]